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Objective: Diabetic retinopathy (DR) is induced by an accumulation of reactive metabolites such as ROS, RNS, and RCS species, which were
reported to modulate the activity of cation channels of the TRPC family. In this study, we use Trpc1/4/5/6/ compound knockout mice to analyze
the contribution of these TRPC proteins to diabetic retinopathy.
Methods: We used Nanostring- and qPCR-based analysis to determine mRNA levels of TRPC channels in control and diabetic retinae and retinal
cell types. Chronic hyperglycemia was induced by Streptozotocin (STZ) treatment. To assess the development of diabetic retinopathy, vaso-
regression, pericyte loss, and thickness of individual retinal layers were analyzed. Plasma and cellular methylglyoxal (MG) levels, as well as
Glyoxalase 1 (GLO1) enzyme activity and protein expression, were measured in WT and Trpc1/4/5/6/ cells or tissues. MG-evoked toxicity in
cells of both genotypes was compared by MTT assay.
Results: We find that Trpc1/4/5/6/ mice are protected from hyperglycemia-evoked vasoregression determined by the formation of acellular
capillaries and pericyte drop-out. In addition, Trpc1/4/5/6/ mice are resistant to the STZ-induced reduction in retinal layer thickness. The RCS
metabolite methylglyoxal, which represents a key mediator for the development of diabetic retinopathy, was significantly reduced in plasma and
red blood cells (RBCs) of STZ-treated Trpc1/4/5/6/ mice compared to controls. GLO1 is the major MG detoxifying enzyme, and its activity and
protein expression were significantly elevated in Trpc1/4/5/6-deficient cells, which led to significantly increased resistance to MG toxicity. GLO1
activity was also increased in retinal extracts from Trpc1/4/5/6/ mice. The TRPCs investigated here are expressed at different levels in
endothelial and glial cells of the retina.
Conclusion: The protective phenotype in diabetic retinopathy observed in Trpc1/4/5/6/ mice is suggestive of a predominant action of TRPCs
in Müller cells and microglia because of their central position in the retention of a proper homoeostasis of the neurovascular unit.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Reactive metabolites (RM), which accumulate under hyperglycemia,
include reactive carbonyl (RCS), oxygen (ROS), and nitrogen (RNS)
species, all of which contribute to the progression of diabetic long-term
complications [1]. Such metabolites can impair the function of multiple
cell types involved in diabetes-associated organ dysfunction leading to
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cation channels have been identified as target molecules of such me-
tabolites accumulating under hyperglycemia. The dicarbonyl methyl-
glyoxal binds to NaV1.8 sodium channels to reduce inactivation and
increase the excitability of nociceptive neurons [3]. Extracellular
application of MG also activates TRPA1 channels by reversible binding
to cysteine residues following permeation of the cell membrane. MG-
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calcium concentration and subsequent release of Calcitonin Gene-
related Peptide (CGRP) [4]. TRPA1 mediates MG-evoked acute pain
sensation [5], but the causal contribution of TRPA1 to long-term com-
plications is not established. Other diabetes-associated reactive me-
tabolites, such as ROS and RNS, also significantly modulate the activity
of cation channels of the TRP family including TRPC channels [6,7].
TRPC channels (TRPC1-TRPC7) are mammalian homologs of trp
channels, originally discovered in Drosophila photoreceptor cells.
Structurally, these channels have six transmembrane domains, and the
pore is formed by transmembrane domain 5 and 6. Based upon the
structural homology, the TRPC family can be divided into three sub-
groups, TRPC1/TRPC4/TRPC5, TRPC3/TRPC6/TRPC7, and TRPC2.
FRET based assays and immunoprecipitations, using synaptosomal
protein fractions from cerebellum or cortex, have provided evidence for
the interaction of TRPC1, TRPC4, and TRPC5, suggesting that they
form heteromeric channels [8,9]. Recently, the formation of hetero-
meric channels by TRPC1, TRPC4, and TRPC5 was demonstrated using
quantitative high-resolution mass spectrometry on affinity-purifications
(APs) from total brain and in hippocampus neurons using isoform
specific antibodies [10]. In the embryonic brain, TRPC1 and TRPC4
could also be co-immunoprecipitated with TRPC6 [11].The cation
channels formed by TRPC proteins are permeant for Ca2þ and Naþ
under physiological conditions and are activated in response to acti-
vation of phospholipase C-coupled receptors but also by various
reactive metabolites accumulating under diabetic conditions [12,13].
For TRPC5, it has been shown that nitric oxide (NO) donors lead to S-
nitrosylation of cysteine residues in the channel pore, evoking an
increased open probability of the channel [14]. TRPC5 channel activity
was also increased by application of the reduced form of thioredoxin
[15] or by application of oxidised glutathione (GSSG) [16]. TRPC1 and
TRPC4 modulate the sensitivity of TRPC5 channels towards RNS and
ROS [14]. TRPC3, TRPC4, and TRPC6 were also found to be redox-
sensitive channels, and their expression and activity were reported
to be modulated by ROS species [17,18].
Numerous studies have investigated the differential regulation of
members of the TRPC subfamily in experimental models of diabetes,
including the streptozotocin (STZ) model, Zucker obese rat, Goto-
Kakizaki rats, and db/db mice, as well as in human cells cultured
under hyperglycemic conditions. However, depending on the study and
the model system used, contradictory findings have been reported with
respect to the transcription and expression of the TRPCs [19]. So far,
the functional relevance of TRPC cation channels in diabetic compli-
cations was primarily analyzed at the cellular level, e.g. in cells
contributing to microangiopathy and nephropathy such as cultured
vascular smooth muscle cells, platelets or mesangial cells [19]. The
relevance of TRPCs for diabetic complications has not been studied in
complex disease models, in part, due to the lack of specific antagonists
for individual TRPC channels, as well as the limitations of knock-down
approaches for long-term studies in vivo.
To date, diabetic retinopathy is a prevalent complication, and is ex-
pected to increase in magnitude, given the global epidemic of type 2
diabetes, and the lack of a specific systemic treatment beyond glucose
control. Treatments such as laser photocoagulation and intravitreal
injections of anti-proliferative or anti-inflammatory agents aim at late
disease stages, are invasive by nature, and have significant side effects.
Diabetic retinopathy (DR) in rodents and humans affects almost all cell
types and culminates in impaired function and structure from the point
of inception. The initial vascular phenotype is vasoregression, i.e. the
loss of pericytes and endothelial cells. Neurodegeneration leading to a
reduction of retinal thickness can occur as a consequence of pro-
gressive retinal capillary drop-out [20] but also as an independentMOLECULAR METABOLISM 9 (2018) 156e167  2018 The Authors. Published by Elsevier GmbH. This is an op
www.molecularmetabolism.comprocess involving progressive cell death by apoptosis. In this process,
accumulation of reactive metabolites and MG can play an important
role [20,21].
In this study, the causal contribution of four TRPC proteins, TRPC1,
TRPC4, TRPC5, and TRPC6, was investigated with respect to their role
in DR by comparing Trpc1/4/5/6/(TRPC QKO) mice to wild-type
controls in the STZ-induced model of diabetes.
2. METHODS
2.1. Mice
To analyze the mRNA expression level of TRPCs by Nanostring, we
used wild-type and Ins2Akita mice with C57BL/6J background as a
model for type 1 diabetes [22]. The quadruple Trpc knockout mouse
line Trpc1/4/5/6/ was generated by intercrossing mice of the four
mouse lines Trpc1/ [23], Trpc4/ [24], Trpc5/ [25], and
Trpc6/ [26] mice. The Trpc1/4/5/6/ mice had a mixed C57Bl6-
129SvJ genetic background, and age and sex matched first genera-
tion (F1) offspring of C57Bl6/N and 129SvJ matings were used as
controls. Trpc1/4/5/6/ mice were routinely genotyped using primers
specific for the corresponding Trpc-deficient alleles as described
before [23e26]. Both mouse lines were bred and maintained at our
university’s Specific Pathogen Free (SPF) central animal facility. We
used 8e12 weeks old male mice and treated them with STZ (Sigmae
Aldrich, Taufkirchen, Germany) as described previously [3]. Briefly,
mice received one STZ injection/day i.p. (60 mg/kg) for five days, and
blood glucose levels were maintained in the range of 300e500 mg/dl
by insulin glargine treatment twice weekly according to blood glucose
levels (Accu-Chek Aviva, Roche, Mannheim, Germany). Glycated he-
moglobin (HbA1c) was determined by cation-exchange chromatog-
raphy on a PolyCAT A column [27]. Mice were kept in standard 12 h
light/dark cycle and provided free access to standard chow diet and
water. Markers for retinopathy, neurodegeneration, and methylglyoxal
measurement were analyzed 30 weeks after the development of hy-
perglycemia. All animal experiments were conducted in accordance
with the relevant guidelines by the EU Directive 2010/63/EU and
approved by the local Animal Care and Use Committee at the regional
authority in Karlsruhe, Germany.
2.2. Analysis of TRPC expression in retina
Total RNA was extracted from retinae of 8-month-old Ins2Akita mice
and nondiabetic control mice using TRIZOL method (Thermo Fisher,
Germany). RNA concentrations were measured using spectropho-
tometer (Infinite 200 PRO Nanoquant, TECAN, Austria) and microfluidic
analysis (Bioanalyzer 2100, Agilent Technologies, USA). Analysis of the
transcripts was done by NCounter Nanostring technology in a three-
step method described by Geiss et al. [28]. Briefly, in the first step,
two probes, the reporter and the capture probe, hybridize directly to the
target molecule in solution. Then, the targeteprobe complexes are
immobilized on the imaging surface of the nCounter Cartridge by
binding to the capture probe. Finally, the sample cartridges are
scanned by an automated fluorescence microscope, and molecular
barcodes (fluorophores contained in the reporter probe) for each
specific target are counted. For expression analysis by NCounter
NanoString technology, 1 mg total RNA was hybridized (four biological
replicates, RIN> 8.3) with a Nanostring Gene Expression CodeSet and
analyzed using the nCounter Digital Analyzer (Nanostring Technolo-
gies, Seattle, USA). Background correction was performed, and
normalization was applied using 5 different reference genes (Hprt1,
Tbp, Ubc, Gapdh, Actb). Trpc specific DNA sequences used are listed in
Supplementary Table 1.en access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 157
Figure 1: TRPC mRNA expression in Retina by qPCR. (A) RNA was extracted from retina
of wild type mice 30 weeks after STZ or Citrate treatment. Absolute mRNA expression
level of Trpc transcripts were normalized to expression level of house-keeping genes
[n ¼ 4 (8 retinae) for WT citrate and n ¼ 5 (10 retinae) WT STZ samples].
Original Article2.3. Quantification of vasoregression and pericyte loss
Quantitative retinal morphometry was performed on retinal digest
preparations to evaluate numbers of acellular capillaries (ACs/mm2
retinal area) and pericytes (pericytes/mm2 capillary area), according to
published methods [29]. Briefly, after enucleation, eyes were fixed in
4% formalin for two days at room temperature. Retinae were isolated
from the eyeball by opening it from the ora serrate. Isolated retinae
were digested with 3% trypsin at 37 C until the photoreceptor layer,
and other retinal layers were digested, leaving behind the vasculature
that can be seen under the low magnification microscope. To visualize
the retinal morphology and morphometry, PAS staining was performed
on the digested retinae. Microscopic quantification of acellular capil-
laries was done using the Cell-F software (Olympus opticals, Hamburg,
Germany). Acellular capillaries were analyzed in ten randomly selected
areas of the central retina (the area around the optic nerve). The total
number of acellular capillaries was calculated to the total retina area.
The total number of pericytes was analyzed in the ten randomly
selected fields in the central retina under 400x magnification.
2.4. Expression analysis in cell lines and retinae using qPCR
RNA isolation was performed using the RNeasy Mini kit (Qiagen) ac-
cording to manufacturer’s protocol for cells, including on-column
DNase digest. For human Müller cells, cells were derived from one
retina, for rat brain microglia from one Sprague Dawley rat, for Bovine
Retinal Endothelial cells (BRECs) from 15 bovine retinae. cDNA syn-
thesis was carried out using the SensiFAST cDNA synthesis kit (Bioline)
according to manufacturer’s recommendations. Primers were
designed with the online tool provided by Roche (https://lifescience.
roche.com/en_de/brands/universal-probe-library.html) and the best
primer pair for each target out of 2e3 was chosen from an initial qPCR
screen. Quantitative expression analysis was performed using the
Universal Probe system (Roche) with the corresponding FastStart
Essential DNA Probes Master (Roche) on a LightCycler 96 Instrument
(Roche, Mannheim, Germany). Relative expression levels were ob-
tained by normalizing to H3F3A, AIP and CXXC1 expression levels.
Primer sequences can be found in the Supplementary Tables 2e4.
2.5. Retinal thickness and nuclei count
Analyzes of thickness and number of cells in retinal nuclear layers
were performed as described before [30]. Briefly, 3 mm thick Periodic
Acid Schiff’s (PAS)- and hematoxylin-stained paraffin sections were
used, and areas near the optic nerve were selected for measurements
of the central retina using a microscope (Olympus, Hamburg, Germany)
equipped with an analysis program (Olympus, Cell-F, Hamburg, Ger-
many). The thickness of the entire retina and all retinal layers is
expressed in mm. The number of cells in the ganglion cell layer is
expressed per 250 mm of retinal length, the inner nuclear layer per
100 mm of retinal length and the outer nuclear layer per 50 mm of
retinal length.
2.6. Methylglyoxal measurement in RBCs and plasma
The concentration of methylglyoxal in EDTA plasma and isolated RBCs
was determined by derivatization with 1,2-diamino-4,5-
dimethoxybenzene, according to the method described by McLellan
[31].
2.7. Glyoxalase 1 activity
GLO1 activity was determined spectrophotometrically as described
previously [32]. Briefly, the initial rate of change in absorbance at
235 nm, caused by the formation of S-D-lactoylglutathione by GLO1, is
monitored. The assay mixture contained 2 mmol/L MG and 2 mmol/L158 MOLECULAR METABOLISM 9 (2018) 156e167  2018 The Authors. Published by Elsevier GmbH. ThiGSH in sodium phosphate buffer (50 mmol/L, pH 6.6, 37 C) and was
incubated for 10 min to guarantee the complete formation of hemi-
thioacetal (HTA). After the addition of the cytosolic protein fraction
(5 mg/10 mL protein), the change in absorbance at 235 nm was
monitored for 10 min. The activity of GLO1 is expressed in units (U),
where 1 U is the amount of GLO1 which catalyzes the formation of
1 mmol/L of S-D-lactoylglutathione per minute.
2.8. Glyoxalase 1 protein expression
MEFs cytoplasmic extracts were used for GLO1 protein expression
analysis using western blot. Samples were loaded on a precast
4e12% gel (Invitrogen, Germany) and run at 80 V for 15 min and after
that at 130 V for more than 1 h until the dye front reached the bottom of
the gel. Samples were blotted onto a nitrocellulose membrane using
Bis-Tris blotting buffer containing 20% methanol. Blotting was done at
9 V for 1 h. After blotting, the membrane was blocked with 5% milk
powder in 1x TBS-T. Blocking was followed by brief washing with 1x
TBS-T, and then, the membrane was incubated in the primary GLO1
antibody (1:1000 diluted) (Abcam, UK) 12e15 h or overnight. The next
day, the membrane was washed briefly with 1x TBS-T and then
incubated for more than 2 h with an anti-rabbit secondary antibody
(1:50000 diluted) (GE Healthcare, UK). After washing briefly with 1x
TBS-T, protein bands were detected by ECL chemiluminescence.
Densitometric analysis was done to determine the intensity of
immunostainings using Image J software. The signal intensity obtained
by the anti-GLO1 antibody was normalized to the signal intensity ob-
tained by anti-a-Tubulin staining.
2.9. MTT assay
MEFs were seeded in 96 well-plates at a density of 25.000 cells per
well and incubated overnight at 37 C (5% CO2). The next day, cells
were washed with PBS and then incubated with MG at the concen-
tration indicated for 48 h. After that, 50 mL of MTT solution (2 mg/mL in
H2O) was applied, and cells were incubated for 3 h. Subsequently, the
medium was removed, and cells were lysed with 200 mL of DMSO. To
dissolve the formazan crystals completely, the plate was incubated for
another hour at room temperature, and then absorbance was
measured at 590 nm with 620 nm as reference wavelength. Cell
viability was calculated by normalizing the absorbance values fors is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Vasoregression and pericyte loss in diabetic retinae. (A) Representative images of PAS-stained retinal digest preparations. Acellular capillaries (AC) are marked with
black arrows, scale bar represents 20 mm. (B) The number of pericytes per mm2 of the capillary area was calculated from ten random selected fields of the circular area around
the optic nerve. (C) The number of acellular capillaries per mm2 of retina tissue was also analyzed in ten random selected fields of the circular area around the optic nerve. The
number of animals analyzed for both acellular capillaries and pericyte loss was n ¼ 5 in WT control, n ¼ 6 in WT STZ-treated, n ¼ 6 in Trpc1/4/5/6/ mice (TRPC QKO) control,
n ¼ 5 in TRPC QKO STZ-treated, ***p < 0.001.
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Figure 3: Analysis of central retinal thickness. (A) Representative images of retinal layers for all experimental groups, scale bar represents 50 mm. (B) Total retinal thickness
and thickness of each retinal layer at the center were measured in diabetic WT and Trpc1/4/5/6/ (TRPC QKO) mice and in the respective non-diabetic controls. ONL: Outer
nuclear layer, INL: Inner nuclear layer, GCL: Ganglionic cell layer, OPL: Outer plexiform layer, IPL: Inner plexiform layer, PRL: Pigmented retinal layer. (n ¼ 4 for WT and TRPC QKO
diabetic and for the respective controls, *p < 0.05, **p < 0.01 and ***p < 0.001). (C) Analysis of number of nuclei in central retina in different retinal layers. A total number of
nuclei in each retinal layer was counted in diabetic WT and TRPC QKO mice and also in their non-diabetic controls (n ¼ 4 for WT and TRPC QKO diabetic and non-diabetic controls).
Original Article
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Figure 4: Methylglyoxal levels in plasma and red blood cells. (A) and (B) 30 weeks after STZ treatment, methylglyoxal levels were measured in plasma (a) and red blood cells
(RBCs) (b) of diabetic WT and Trpc1/4/5/6/ (TRPC QKO) mice and also in the non-diabetic control groups with a HPLC-based assay. MG levels were normalized to total
haemoglobin and protein content in RBCs and plasma, respectively (n ¼ 10 mice for nondiabetic WT controls, n ¼ 14 diabetic WT mice, n ¼ 11 mice for non-diabetic TRPC QKO
controls, n ¼ 7 diabetic TRPC QKO mice, *p < 0.05, **p < 0.01 and ***p < 0.001).treated cells with the absorbance values of non-treated cells and
expressed in percent.
2.10. Isolation of mouse embryonic fibroblast (MEF) cells
Primary mouse embryonic fibroblast (MEF) cells were isolated from
E13.5 wild-type control and Trpc1/4/5/6/ embryos, respectively, as
described previously [24,33]. Cells were propagated in DMEM high
glucose medium (Invitrogen, Germany) and used at passage 2 for
enzyme activity, western blot, and MTT assay.
2.11. Statistical analysis
Results are shown as mean  SD, unless stated otherwise. Statistical
significance for Figures 2e4 and Supplementary Figure 1 was
determined by two-way ANOVA (Tukey Test) whilst two-tailed unpaired
Student’s t-test was used in all other figures. Differences with
p < 0.05 were considered statistically significant. Significances are
depicted as * p < 0.05, ** p < 0.01, and *** p < 0.001.
3. RESULTS
3.1. TRPC channels are abundantly expressed in retina
The expression pattern of Trpc genes in the retina under diabetic
conditions was assessed using qPCR-based RNA analysis from citrateMOLECULAR METABOLISM 9 (2018) 156e167  2018 The Authors. Published by Elsevier GmbH. This is an op
www.molecularmetabolism.comand STZ-treated wild type mice (Figure 1). Several TRPC channels
were found to be abundantly expressed in the mouse retina. Tran-
scripts of Trpc1, Trpc2 (a pseudogene in humans), Trpc3, and Trpc4
showed the highest relative expression, but Trpc5, Trpc6, and Trpc7
were also identified. In addition, we studied Trpc transcript abundance
using a Nanostring-based RNA analysis in retinae of 32-week old
control and Ins2Akita mice, which spontaneously develop diabetes due
to a missense mutation in the insulin 2 gene. Also, here, most TRPC
channels were found to be abundantly expressed. Specifically, Trpc1
mRNA was detected at very high levels, followed by Trpc3, Trpc4, and
Trpc6 transcript levels in control as well as in the diabetic retinae.
Expression of TRPC5 was also detectable. Notably, Trpc6 transcript
levels were significantly higher in the retina of Ins2Akita mice compared
to controls indicating an upregulation of TRPC6 transcripts under
diabetic conditions (Supplementary Figure 2A).
3.2. Trpc1/4/5/6 quadruple knockout mice are protected from
experimental diabetic retinopathy
To study the contribution of several TRPCs simultaneously in the
diabetic condition, the Trpc compound knockout mouse line Trpc1/4/5/
6/ was used. In these mice, cation channels formed by TRPC1-,
TRPC4-, TRPC5- and/or TRPC6 which are all subject to modulation by
reactive metabolites have been inactivated. After 30 weeks of constanten access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 161
Original Articlehyperglycemia, mice were killed and retinopathy was assessed. In
STZ-diabetic wild-type mice, we observed a marked decrease in the
number of pericytes compared to non-diabetic controls. In contrast,
diabetic Trpc1/4/5/6/ mice were completely protected from pericyte
loss (Figure 2B). Consecutively, the formation of acellular capillaries as
a measure of both, pericyte and endothelial cell loss, was increased in
hyperglycemic control mice compared to the normoglycemic condition
(Figure 2A,C), but in diabetic Trpc1/4/5/6/ mice, formation of
acellular capillaries was completely absent (Figure 2A,C).
These results suggest that TRPC1-, TRPC4-, TRPC5-, and TRPC6-
containing cation channels contribute to diabetic vasoregression.
3.3. Diabetes-evoked retinal neurodegeneration is reduced in
Trpc1/4/5/6 quadruple knockout mice
We also aimed to analyze whether TRPC1/4/5/6 proteins play a role in
neurodegeneration in the retina induced by the metabolic changes
under chronic hyperglycemia. STZ-induced hyperglycemia reduced the
overall retinal thickness, composed of the thickness of individual
retinal layers measured in the center of the retina. Specifically, the
outer nuclear layer (ONL), the inner nuclear layer (INL), the outer
plexiform layer (OPL), the inner plexiform layer (IPL) and the pigmented
retinal layer (PRL) were reduced in thickness under diabetic conditions
in wild-type mice. Only the ganglion cell layer (GCL) was unaffected by
diabetes (Figure 3A,B). In contrast, there was no hyperglycemia-
induced change in the thickness in any retinal cell layer in Trpc1/4/
5/6/ mice. The number of nuclei in the retina of both wild-type and
Trpc1/4/5/6/ mice was unchanged (Figure 3C).
3.4. TRPC channels are involved in the accumulation of reactive
metabolites in tissues
To investigate the observed protection against the development of
diabetic retinopathy in Trpc1/4/5/6/ mice, we asked whether Trpc1/
4/5/6/ mice were exposed to a comparable glucose-dependent
metabolic stress as wild-type controls, even though the HbA1c levels
were not different between the two genotypes (Supplementary
Figure 1A). An increase in the levels of the reactive metabolite
methylglyoxal is known to mediate the development of diabetic reti-
nopathy and was found in plasma samples of STZ-diabetic wild-type
mice. However, in STZ-diabetic Trpc1/4/5/6/ mice, the rise of MG
plasma levels was significantly reduced compared to the STZ-treated
wild-type group (Figure 4A). To examine whether the reduced extra-
cellular accumulation of MG is also observed inside the cell, MG
content in red blood cells (RBCs) was analyzed, and results show that
the STZ-induced increase in MG levels in wild-type RBCs was again
significantly reduced in Trpc1/4/5/6/ mice to a similar extent as in
the plasma (Figure 4B). These results suggest that TRPC channels are
involved in the accumulation of the major hyperglycemia-related
reactive metabolite MG.
3.5. Increased Glyoxalase 1 activity and protein expression
enhances MG tolerance in Trpc1/4/5/6/ cells
As GLO1 is a key enzyme in the detoxification of MG, we measured
GLO1 enzyme activity in MEFs derived from Trpc1/4/5/6/ mice. We
detected a significant increase in GLO1 activity in Trpc1/4/5/6/
MEFs (Figure 5A), which was accompanied by an increased expression
of the GLO1 protein (Figure 5B). We hypothesized that Trpc1/4/5/6/
cells are more resistant towards MG due to this increase in GLO1
activity. To test this hypothesis, MTT-based viability assays were
performed. We detected a right shift in the doseeresponse curve in
Trpc1/4/5/6/ MEFs (IC50 484  108 mmol/L) as compared to wild-
type controls (IC50 305  31 mmol/L, Figure 5C). Accordingly, the162 MOLECULAR METABOLISM 9 (2018) 156e167  2018 The Authors. Published by Elsevier GmbH. Thipercentage of viable Trpc1/4/5/6/ MEFs was significantly higher
compared to wild-type controls at a MG concentration of 500 mmol/L,
indicating that they can tolerate detrimental MG levels better than the
wild-type controls (Figure 5C, insert).
3.6. Increased Glyoxalase 1 activity in the retina may confer
protection against development of diabetic retinopathy in Trpc1/4/5/
6/ mice
The increased GLO1 activity detected in MEFs could be confirmed
in vivo in the retinae isolated from Trpc1/4/5/6/ mice (Figure 6A,B).
To analyze the expression of TRPC channels in cell types relevant to the
development of DR, we measured mRNA levels in primary human
Müller cells, in primary rat brain microglia and bovine retinal endo-
thelial cells via quantitative real-time PCR (qPCR). Predominant and
very high expression of TRPC1 compared to reference genes was
observed in human Müller cells (Figure 6C) with Trpc4 and Trpc5
mRNAs also being detected. In rat microglia (Figure 6D), Trpc1 was
also the major family member expressed in these cells, accompanied
by low levels of Trpc6 mRNA. In bovine retinal ECs (Figure 6E), Trpc1,
Trpc4, and Trpc5 transcripts were highly abundant and Trpc2, and
Trpc6 mRNAs were present at low levels. Thus, Trpc1 is highly
expressed in all cell types tested, and Trpc4 and Trpc5 are present in
relevant amounts in Müller cells and retinal ECs.
4. DISCUSSION
In this study, we find that Trpc1/4/5/6/ mice are protected from
damage to the neurovascular unit and lack hyperglycemia-evoked
vasoregression, a hallmark of DR, determined by the formation of
acellular capillaries and pericyte drop-out. DR is accompanied by
microangiopathic and neurodegenerative changes and cell death,
which also leads to a reduction in overall thickness and thickness of
the single retinal layers. However, the retinal layer thickness is un-
changed by hyperglycemic conditions in Trpc1/4/5/6/ mice in
contrast to a marked reduction of layer thickness in hyperglycemic
wild-types in all layers except the retinal ganglion cell layer.
Diabetic complications such as retinopathy are mediated by an
accumulation of reactive metabolites that include ROS, RNS, and RCS
species. TRPC channel function can be modulated by such metabo-
lites, but so far, a causative contribution of TRPC channels to diabetic
complications has not been shown. Despite similar levels of hyper-
glycemia, Trpc1/4/5/6/ mice showed reduced accumulation of the
reactive metabolite methylglyoxal in plasma and RBCs. MG has been
shown to contribute to the pathology of DR [21]. GLO1 is considered as
the major enzyme involved in the detoxification of MG, and we found an
increase in GLO1 enzyme activity in MEFs derived from TRPC1/4/5/6-
deficient mice and in retina lysates from these mice. GLO1 protein
levels were also increased compared to wild-type mice. We found this
increase in GLO1 activity to be sufficient to mediate significant pro-
tection from MG-evoked cellular toxicity. These results indicate that
TRPC channels containing any of the four TRPC1/C4/C5/C6 proteins
are involved in the regulation of GLO1 activity, and loss of these
channels leads to an increase in GLO1 activity and MG detoxification
which may confer protection from retinopathic changes in vivo.
As we used TRPC-deficient mice with ubiquitous deletion of these
proteins, our approach did not allow to differentiate in which retinal cell
type(s) these channel proteins contribute to the development of reti-
nopathy. However, we identified abundant expression of TRPC1, C4,
and C5 in bovine retinal endothelial cells, which form heteromeric
channels in other cells such as hippocampal neurons [10]. Additionally,
we found TRPC1 to be predominantly expressed in rat brain microglials is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: Increased Glyoxalase 1 activity and protein expression enhance MG
tolerance in Trpc1/4/5/6L/L cells. (A) Cytoplasmic extracts of lysed mouse em-
bryonic fibroblasts (MEFs) were used to determine glyoxalase 1 (GLO1) activity. The bar
graph shows the averaged GLO1 activity from three independent wild-type and Trpc1/
4/5/6/ MEF preparations (*p < 0.05). (B) Upper panel: GLO1 protein expression in
MEFs was analyzed in cytoplasmic extracts from MEF cells. Immunoblot with samples
of 4 independent wild-type (WT1-WT4) and Trpc1/4/5/6/ KO1-KO4) MEF prepara-
tions using anti-GLO1antibody are shown. a-tubulin was used as loading control.
Lower panel: Densitometric quantitative analysis of the western blot shown above. The
bar graph shows the average GLO1 to a-tubulin ratio of the 4 wild-type and TRPC QKO
MEFs samples, respectively (**p < 0.01). (C) Large panel: Dose response curve for
MG-evoked cell toxicity in MEFs. MEFs were incubated with varying concentration of
MOLECULAR METABOLISM 9 (2018) 156e167  2018 The Authors. Published by Elsevier GmbH. This is an op
www.molecularmetabolism.comcells with low levels of TRPC6, but protein expression in mouse retinal
glia cells could not be shown so far because all anti-TRPC antibodies
tested in retinal sections were not able to distinguish between wild-
type and the corresponding TRPC knockout. A functional role of
TRPCs is also conceivable in Müller cells since we find very high
expression of Trpc1 transcripts in primary human Müller cells, but
functional studies investigating TRPC signaling are still lacking for this
cell type. Although the exact mechanism(s) by which GLO1 is modu-
lated through TRPC activity need(s) to be determined, it appears that
Müller cells are central to the homoeostasis of the neurovascular unit.
For example, the receptor for advanced glycation end products, RAGE,
is strongly expressed and upregulated in Müller glia and microglia
under diabetic conditions, and in mice with a deletion of RAGE, pro-
tection from vasoregression is observed [34]. Moreover, when the
reactive metabolite methylglyoxal is reduced by treating diabetic rats
with a DPP-4 inhibitor, both vasoregression and neurodegeneration
are reduced [30]. On the other hand, all four of the TRPC proteins
were previously shown to mediate calcium entry in endothelial cells
[24,35e38]. An exaggerated rise in [Ca2þ]i, that could be triggered by
reactive metabolites including ROS or RNS following hypoxia, leads to
apoptotic death [39] and eventually to the development of acellular
capillaries, which is blunted in the absence of these channel proteins.
The underlying processes of Ca2þ-overload-mediated toxicity may
include over-activation of several types of enzymes, e.g. proteases of
the calpain family, the phosphatase calcineurin, NO synthases and
endonucleases leading to DNA fragmentation. Activation of calcineurin
was shown to be downstream of signaling by TRPCs channels
including TRPC1/C4/C6 [40]. Calpain can cleave and activate TRPC5
and may thus further aggravate this process [41]. In analogy, similar
mechanisms could be envisaged in pericytes to evoke Ca2þ-depen-
dent pericyte loss under diabetic conditions. In contrast to endothelial
cells, pericytes are electrically excitable cells which have voltage-gated
Ca2þ channels (VGCC) in addition to agonist-evoked Ca2þ entry
pathways triggered by GPCR agonists such as ET-1, Ang II or ATP
[42,43], which might be conveyed by TRPC channels in analogy to
vascular smooth muscle cells [44]. Similarly as in astrocytes [45], in
which TRPC channels were reported to coordinate ion signaling, and in
Müller cells, a significant contribution of TRPC channels to such
pathological processes has also not been demonstrated in pericytes,
but ATP-evoked pericyte death was shown to be mediated via P2X7
purinoceptors [42].
The exact entities of TRPC complexes that are thought to consist of
heteromers or homomers of individual TRPC proteins could not be
pinpointed in the retina in our study. TRPC proteins can interact with
STIM1 proteins [46], which contain redox-sensing cysteine residues
[47], but redox-mediated activation of STIM proteins could also engage
cation entry via channels consisting of Orai proteins [47,48]. Under
diabetic conditions, TRPC5-containing channels could be involved in
redox signaling beyond their stimulation by RNS species [6,7,14]. Very
recently, it was reported that the H2O2-evoked ROS production, as well
as premature senescence, was reduced in primary endothelial cells of
TRPC5-deficient mice [49], suggesting that TRPC5 channels are not
only a target of these metabolites but also a determinant of itsMG for 48 h. The percentage of living cells was determined by MTT assay. Closed black
squares represent the average of viable wild-type MEFs and the closed white circles
the percentage of viable Trpc1/4/5/6/ MEFs at the given MG concentrations. Three
independent wild-type and Trpc1/4/5/6e/eMEF preparations were analyzed
(**p < 0.01). The insert shows a bar graph of the mean values from the MTT assay for
the three MEF preparations per genotype after treatment with 500 mmol/L MG
(**p < 0.01, error bars: SEM).
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Figure 6: Increased Glyoxalase 1 activity in the retinae of Trpc1/4/5/6L/L mice. (A) The retinae were lysed by sonication, and cytoplasmic extracts were used to determine
GLO1 activity and normalized to the total protein content in the cytoplasmic extracts. GLO1 activity for retinal extracts of five individual wild-type (WT1-5) and Trpc1/4/5/6/ mice
(KO1-5) is displayed (*p < 0.05). (B) Average GLO1 activity of the 5 wild-type and 5 Trpc1/4/5/6/ retinae (*p < 0.05) displayed in (a). (C) Relative mRNA expression levels
determined by quantitative real-time PCR (qPCR) analysis of Trpc transcripts in RNA samples derived from human Müller cells (n ¼ 1). (D) Relative expression levels of Trpc
transcripts in RNA samples determined in primary rat brain microglia cells (n ¼ 1). (E) Relative expression levels of Trpc transcripts in RNA samples determined in bovine retinal
endothelial cells (BRECs) (n ¼ 15).
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accumulation. TRPC5 activation was also shown to occur by interaction
with oxidized glutathione (GSSG), which rises intracellularly upon MG
accumulation [50]. GSSG was shown to activate TRPC5-containing
channels via S-glutathionylation [16] and thus, Ca2þ-dependent
cellular processes including cell death are triggered. Increased levels
of the TRPC5 modulator GSSG can be evoked upon long-term exposure
to MG [50,51]. MG accumulation under diabetic conditions leads to a
decrease in endothelial cell number in vessels of mice with STZ-
induced diabetes. Interestingly, EC death was prevented in mice
overexpressing GLO1 [52], and GLO1 activity was shown to depend on
TRPC channels in our study. In addition to the reactive metabolites
mentioned before, a plethora of other agonists able to trigger TRPC
channel activity could be envisaged under diabetic conditions as un-
derlying mechanisms to initiate cellular processes and cell death in
endothelial or other retinal cells. Despite various possible mechanisms
discussed above, the identification of the exact trigger events under-
lying TRPC channel-mediated damage to the neurovascular unit will be
subject for further investigations.
An emerging question for future studies will be to find the functional
link between the presence of TRPC proteins and GLO1-mediated MG
detoxification. Our data in TRPC deficient cells show an increase of
GLO1 protein expression in MEF cells and in the retina homogenates,
suggesting that TRPC function limits GLO1 protein expression and
thereby GLO1 enzyme activity as well as MG detoxification. TRPC
channels could mediate calcium-dependent gene expression via
calcium-dependent transcription factors such as members of the NFAT
family [53]. However, calcium-dependent suppression of genes would
be rather an exception. Alternatively, TRPC function could modulate
post-translational modification of GLO1 proteins. Recently, it was re-
ported that a transient rise in cytosolic calcium levels results in more
persistent ubiquitination of proteins [54,55]. If GLO1 proteins were also
ubiquitylated in a Ca2þ-dependent manner, it would be conceivable
that proteasome-targeting of the ubiquitinated GLO1 proteins and their
degradation is reduced in TRPC-deficient cells. Finally, TRPC-
mediating calcium entry could modulate GLO1 enzyme activity, but a
variation of the calcium concentration across a wide range between
100 nmol/L to 3 mmol/L did not affect GLO1 enzyme activity in our
experiments (data not shown). To corroborate that the increase in
GLO1 expression and activity were responsible for the increased
protection against MG in TRPC QKO cells, GLO1 antagonists could be
used to see whether the improved viability in TRPC QKO MEF cells can
be shifted to the range observed in WT cells. However, application of
the Glo1 inhibitor S-p-bromoglutathione cyclopentyl diester (BBGC)
[56,57] per se evoked considerable (>50%) cell death in MEF cells in
concentrations needed for efficient enzyme inhibition (>5 mM, data not
shown), hampering the significance of such an approach. Alternatively,
the increase in Glo1 expression and enzyme activity does not neces-
sarily denote whether Glo1-independent mechanism(s) also contribute
to detoxification of MG or other reactive metabolites in the absence of
TRPC1/4/5/6. Indeed, we have observed alternative pathways in cells,
in which Glo1 expression and enzyme activity were abolished following
Glo1 gene deletion in Schwann cells; here, we found up-regulation of
genes encoding aldo-keto reductases (AKR) as well as an increase in
AKR enzyme activity [58]. However, we found upregulation of AKR
activity only when GLO1 was completely abolished, and the key en-
zymes of metabolic pathways that might be upregulated in TRPC QKO
cells need to be identified as to causally address the relevance of such
pathways.
Pharmacological inhibition of TRPC channels could be an attractive
future approach for the treatment of DR. Several TRPC blockers have
been described, but there are constraints for in vivo application.MOLECULAR METABOLISM 9 (2018) 156e167  2018 The Authors. Published by Elsevier GmbH. This is an op
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well TRPC1/TRPC4- and TRPC1/TRPC5-heteromeric channels has
been developed [59]. This blocker (compound C31 or pico145) has
been shown to be highly potent (IC50 in the range of 5e1300 pM) and
specific within the TRP channel family. However, its effectiveness in
primary cells and in vivo has not yet been demonstrated. Apart from
C31, there are other TRPC channel blockers available such as
SAR7334 and ML204. SAR7334 blocks TRPC3, TRPC7, and, most
potently, TRPC6 homomeric channels [60]. ML204 was identified as a
TRPC4 and TRPC5 inhibitor. However, its pharmakokinetic properties
limit its use in vivo [61]. SAR7334 application abolished hypoxia-
induced increases in pulmonary arterial pressure in a similar way as
observed in Trpc6/ mice.
Taken together, in this study, we demonstrate a causal contribution of
TRPC proteins for the development of diabetic retinopathy in the mu-
rine STZ model and provide evidence that TRPC-mediated processes
aggravating vasoregression as well as neurodegeneration in the retina
may be due to a TRPC-mediated role in the accumulation of the
reactive metabolite MG and its detoxification by GLO1. However, in
future studies, the exact TRPC-containing channel entities and the cell
type(s) that initiate(s) TRPC-dependent processes in DR need to be
identified to understand the causative role of TRPCs in DR precisely.
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